Showing results (181-190 of 219) with videos related to

Sort By:
Pageof 22
Nature Medicine|January 22, 2020
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphomaJennifer N Brudno, Norris Lam, Danielle Vanasse, et al.
Stem Cell Research & Therapy|May 1, 2026
CAR-T cells targeting fibroblast activation protein eliminate pathological fibroblasts and preserve cardiac function in a Duchenne Muscular Dystrophy murine modelCéline Marigny, Gaëlle Revet, Anne Berger, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 29, 2008
The short esophagus: intraoperative assessment of esophageal lengthSandro Mattioli, Maria Luisa Lugaresi, Mario Costantini, et al.
Blood Cancer Discovery|November 20, 2023
Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)Simone Filosto, Saran Vardhanabhuti, Miguel A Canales, et al.
BMC Cancer|September 24, 2015
Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survivalTadeu Ferreira Paiva, Victor Hugo Fonseca de Jesus, Raul Amorim Marques, et al.
International Journal of Clinical Oncology|October 6, 2010
Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GISTCarla Rameri Alexandre Silva de Azevedo, Tadeu Ferreira Paiva, Benedito Mauro Rossi, et al.
Nature Cancer|May 15, 2024
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profilingAli Rezvan, Gabrielle Romain, Mohsen Fathi, et al.
Cancer Letters|February 24, 2006
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian familiesMaria Isabel Waddington Achatz, Magali Olivier, Florence Le Calvez, et al.
British Journal of Haematology|September 30, 2021
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B-cell lymphomaMax S Topp, Tom van Meerten, Roch Houot, et al.
Journal for Immunotherapy of Cancer|June 27, 2017
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31<sup>st</sup>Annual Meeting of the Society for Immunotherapy of Cancer, 2016Prasad S Adusumilli, Edward Cha, Mark Cornfeld, et al.
Pageof 22